| 000 | 01498 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516222217.0 | ||
| 264 | 0 | _c20150406 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1399-3062 | ||
| 024 | 7 |
_a10.1111/tid.12257 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLyons, J | |
| 245 | 0 | 0 |
_aAn unusual lung mass post stem cell transplantation. _h[electronic resource] |
| 260 |
_bTransplant infectious disease : an official journal of the Transplantation Society _cAug 2014 |
||
| 300 |
_a672-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aClarithromycin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aEthambutol _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xadministration & dosage |
| 650 | 0 | 4 |
_aMycobacterium Infections, Nontuberculous _xmicrobiology |
| 650 | 0 | 4 |
_aMycobacterium kansasii _xdrug effects |
| 650 | 0 | 4 |
_aRifampin _xadministration & dosage |
| 650 | 0 | 4 |
_aStem Cell Transplantation _xadverse effects |
| 700 | 1 | _aVandenberghe, E | |
| 700 | 1 | _aFahy, R | |
| 700 | 1 | _aMcDonnell, C | |
| 700 | 1 | _aKeane, J | |
| 700 | 1 | _aMcLaughlin, A M | |
| 773 | 0 |
_tTransplant infectious disease : an official journal of the Transplantation Society _gvol. 16 _gno. 4 _gp. 672-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/tid.12257 _zAvailable from publisher's website |
| 999 |
_c23981884 _d23981884 |
||